MLYS

NASDAQStock

Mineralys Therapeutics, Inc.

$26.52-0.47 (-1.74%)

52-Week Range

$11.77

$47.33

Key Stats

Market Cap

1.8B

P/E Ratio

—

Dividend Yield

—

Beta

0.57

Volume

883.8K

Avg Volume

1.2M

Performance

-2.21%

-25.07%

-27.87%

YTD

-24.42%

+89.80%

+75.49%

+46.37%

Price Chart

ETF Exposure

MLYS is held by 101 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	13	$574	$337.7M	0.32%

PreviousPage 3 of 3

About MLYS ETF Exposure

Mineralys Therapeutics, Inc. (MLYS) is held by 101 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.8B, MLYS is a widely held institutional stock. The stock currently trades at $26.52. Investors can gain exposure to MLYS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MLYS, sorted by portfolio weight.